Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Other Working Capital Changes (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Other Working Capital Changes for 15 consecutive years, with $304795.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other Working Capital Changes rose 4.23% year-over-year to $304795.0, compared with a TTM value of -$113923.0 through Mar 2025, down 1213.4%, and an annual FY2025 reading of -$113923.0, down 1213.4% over the prior year.
  • Other Working Capital Changes was $304795.0 for Q1 2025 at Aethlon Medical, up from -$126647.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $441413.0 in Q4 2021 and bottomed at -$574245.0 in Q1 2023.
  • Average Other Working Capital Changes over 5 years is $3114.1, with a median of -$89872.0 recorded in 2024.
  • The sharpest move saw Other Working Capital Changes surged 216.28% in 2022, then tumbled 408.44% in 2023.
  • Year by year, Other Working Capital Changes stood at $441413.0 in 2021, then tumbled by 73.98% to $114849.0 in 2022, then plummeted by 135.51% to -$40781.0 in 2023, then plummeted by 210.55% to -$126647.0 in 2024, then surged by 340.66% to $304795.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for AEMD at $304795.0 in Q1 2025, -$126647.0 in Q4 2024, and -$202199.0 in Q3 2024.